-
1
-
-
33646265558
-
Effect of the women's health initiative on osteoporosis therapy and expenditure in Medicaid
-
Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Effect of the women's health initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res 2006; 21:765-71.
-
(2006)
J Bone Miner Res
, vol.21
, pp. 765-771
-
-
Udell, J.A.1
Fischer, M.A.2
Brookhart, M.A.3
Solomon, D.H.4
Choudhry, N.K.5
-
3
-
-
34547793133
-
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005
-
DOI 10.1007/s00228-007-0320-6
-
Watson J, Wise L, Green J. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 2007;63: 843-9. (Pubitemid 47237896)
-
(2007)
European Journal of Clinical Pharmacology
, vol.63
, Issue.9
, pp. 843-849
-
-
Watson, J.1
Wise, L.2
Green, J.3
-
4
-
-
4944239035
-
An amino-bisphosphonate targets MMP-9 - Expressing macrophages and angiogenesis to impair cervical carcinogenesis
-
DOI 10.1172/JCI200422087
-
Giraudo E, Inoue M, Hanahan D. An aminobisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004;114: 623-33. (Pubitemid 39578752)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.5
, pp. 623-633
-
-
Giraudo, E.1
Inoue, M.2
Hanahan, D.3
-
5
-
-
0034783467
-
Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: Application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions
-
Peyruchaud O, Winding B, Pecheur I, Serre CM, Delmas P, Clezardin P. Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions. J Bone Miner Res 2001;16:2027-34. (Pubitemid 32995393)
-
(2001)
Journal of Bone and Mineral Research
, vol.16
, Issue.11
, pp. 2027-2034
-
-
Peyruchaud, O.1
Winding, B.2
Pecheur, I.3
Serre, C.-M.4
Delmas, P.5
Clezardin, P.6
-
6
-
-
0034107048
-
Bisphosphonates induce apoptosis in human breast cancer cell lines
-
Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 2000;82:1459-68. (Pubitemid 30175914)
-
(2000)
British Journal of Cancer
, vol.82
, Issue.8
, pp. 1459-1468
-
-
Senaratne, S.G.1
Pirianov, G.2
Mansi, J.L.3
Arnett, T.R.4
Colston, K.W.5
-
7
-
-
33646725498
-
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs
-
Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RG, Oppermann U. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci USA 2006;103:7829-34.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 7829-7834
-
-
Kavanagh, K.L.1
Guo, K.2
Dunford, J.E.3
Wu, X.4
Knapp, S.5
Ebetino, F.H.6
Rogers, M.J.7
Russell, R.G.8
Oppermann, U.9
-
8
-
-
0032491037
-
Reduction in new metastases in breast cancer with adjuvant clodronate treatment
-
DOI 10.1056/NEJM199808063390601
-
Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med 1998;339:357-63. (Pubitemid 28363797)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.6
, pp. 357-363
-
-
Diel, I.J.1
Solomayer, E.-F.2
Costa, S.D.3
Gollan, C.4
Goerner, R.5
Wallwiener, D.6
Kaufmann, M.7
Bastert, G.8
-
9
-
-
33744828376
-
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]
-
Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Res 2006;8: R13.
-
(2006)
Breast Cancer Res
, vol.8
-
-
Powles, T.1
Paterson, A.2
McCloskey, E.3
Schein, P.4
Scheffler, B.5
Tidy, A.6
Ashley, S.7
Smith, I.8
Ottestad, L.9
Kanis, J.10
-
10
-
-
9444254706
-
Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients
-
DOI 10.1080/02841860410032885
-
Saarto T, Vehmanen L, Virkkunen P, Blomqvist C. Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients. Acta Oncol 2004; 43:650-6. (Pubitemid 39563937)
-
(2004)
Acta Oncologica
, vol.43
, Issue.7
, pp. 650-656
-
-
Saarto, T.1
Vehmanen, L.2
Virkkunen, P.3
Blomqvist, C.4
-
11
-
-
49949115926
-
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bonemineral density substudy
-
Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kassmann H, Piswanger-Solkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, et al. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bonemineral density substudy. Lancet Oncol 2008;9: 840-9.
-
(2008)
Lancet Oncol
, vol.9
, pp. 840-849
-
-
Gnant, M.1
Mlineritsch, B.2
Luschin-Ebengreuth, G.3
Kainberger, F.4
Kassmann, H.5
Piswanger-Solkner, J.C.6
Seifert, M.7
Ploner, F.8
Menzel, C.9
Dubsky, P.10
Fitzal, F.11
Bjelic-Radisic, V.12
-
12
-
-
67649804881
-
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results
-
Brufsky AM, Bosserman LD, Caradonna RR, Haley BB, Jones CM, Moore HC, Jin L, Warsi GM, Ericson SG, Perez EA. Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results. Clin Breast Cancer 2009;9: 77-85.
-
(2009)
Clin Breast Cancer
, vol.9
, pp. 77-85
-
-
Brufsky, A.M.1
Bosserman, L.D.2
Caradonna, R.R.3
Haley, B.B.4
Jones, C.M.5
Moore, H.C.6
Jin, L.7
Warsi, G.M.8
Ericson, S.G.9
Perez, E.A.10
-
13
-
-
77954580167
-
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
-
Eidtmann H, de Boer R, Bundred N, Llombart-Cussac A, Davidson N, Neven P, von Minckwitz G, Miller J, Schenk N, Coleman R. Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study. Ann Oncol 2010;21:2188-94.
-
(2010)
Ann Oncol
, vol.21
, pp. 2188-2194
-
-
Eidtmann, H.1
De Boer, R.2
Bundred, N.3
Llombart-Cussac, A.4
Davidson, N.5
Neven, P.6
Von Minckwitz, G.7
Miller, J.8
Schenk, N.9
Coleman, R.10
-
14
-
-
77649269901
-
Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
-
Newcomb PA, Trentham-Dietz A, Hampton JM. Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk. Br J Cancer 2010;102:799-802.
-
(2010)
Br J Cancer
, vol.102
, pp. 799-802
-
-
Newcomb, P.A.1
Trentham-Dietz, A.2
Hampton, J.M.3
-
15
-
-
77955870208
-
Use of bisphosphonates and risk of postmenopausal breast cancer
-
Rennert G, Pinchev M, Rennert HS. Use of bisphosphonates and risk of postmenopausal breast cancer. J Clin Oncol 2010;28:3577-81.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3577-3581
-
-
Rennert, G.1
Pinchev, M.2
Rennert, H.S.3
-
16
-
-
77955875028
-
Oral bisphosphonate use and breast cancer incidence in postmenopausal women
-
Chlebowski RT, Chen Z, Cauley JA, Anderson G, Rodabough RJ, McTiernan A, Lane DS, Manson JE, Snetselaar L, Yasmeen S, O'Sullivan MJ, Safford M. Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol 2010;28:3582-90.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3582-3590
-
-
Chlebowski, R.T.1
Chen, Z.2
Cauley, J.A.3
Anderson, G.4
Rodabough, R.J.5
McTiernan, A.6
Lane, D.S.7
Manson, J.E.8
Snetselaar, L.9
Yasmeen, S.10
O'Sullivan, M.J.11
Safford, M.12
-
17
-
-
77956542068
-
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Case-control analysis within a UK primary care cohort
-
Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 2010;341:c4444.
-
(2010)
BMJ
, vol.341
-
-
Green, J.1
Czanner, G.2
Reeves, G.3
Watson, J.4
Wise, L.5
Beral, V.6
-
19
-
-
77955369368
-
Exposure to oral bisphosphonates and risk of esophageal cancer
-
Cardwell CR, Abnet CC, Cantwell MM, Murray LJ. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA 2010;304:657-63.
-
(2010)
JAMA
, vol.304
, pp. 657-663
-
-
Cardwell, C.R.1
Abnet, C.C.2
Cantwell, M.M.3
Murray, L.J.4
-
20
-
-
0025856399
-
Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
-
Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
-
(1991)
BMJ
, vol.302
, pp. 766-768
-
-
Jick, H.1
Jick, S.S.2
Derby, L.E.3
-
21
-
-
54049109591
-
Breast cancer and use of nonsteroidal anti-inflammatory drugs: A meta-analysis
-
Takkouche B, Regueira-Mendez C, Etminan M. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 2008;100:1439-47.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1439-1447
-
-
Takkouche, B.1
Regueira-Mendez, C.2
Etminan, M.3
-
22
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010;376:1741-50.
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
Norrving, B.4
Algra, A.5
Warlow, C.P.6
Meade, T.W.7
-
23
-
-
56749171092
-
Calcium plus vitamin D supplementation and the risk of breast cancer
-
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008;100:1581-91.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1581-1591
-
-
Chlebowski, R.T.1
Johnson, K.C.2
Kooperberg, C.3
Pettinger, M.4
Wactawski-Wende, J.5
Rohan, T.6
Rossouw, J.7
Lane, D.8
O'Sullivan, M.J.9
Yasmeen, S.10
Hiatt, R.A.11
Shikany, J.M.12
-
24
-
-
32644484304
-
Calcium plus vitamin D supplementation and the risk of colorectal cancer
-
DOI 10.1056/NEJMoa055222
-
Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96. (Pubitemid 43247139)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.7
, pp. 684-696
-
-
Wactawski-Wende, J.1
Morley, K.J.2
Anderson, G.L.3
Assaf, A.R.4
Brunner, R.L.5
O'Sullivan, M.J.6
Margolis, K.L.7
Ockene, J.K.8
Phillips, L.9
Pottern, L.10
Prentice, R.L.11
Robbins, J.12
Rohan, T.E.13
Sarto, G.E.14
Sharma, S.15
Stefanick, M.L.16
Van Horn, L.17
Wallace, R.B.18
Whitlock, E.19
Bassford, T.20
Beresford, S.A.A.21
Black, H.R.22
Bonds, D.E.23
Brzyski, R.G.24
Caan, B.25
Chlebowski, R.T.26
Cochrane, B.27
Garland, C.28
Gass, M.29
Hays, J.30
Heiss, G.31
Hendrix, S.L.32
Howard, B.V.33
Hsia, J.34
Hubbell, F.A.35
Jackson, R.D.36
Johnson, K.C.37
Judd, H.38
Kooperberg, C.L.39
Kuller, L.H.40
LaCroix, A.Z.41
Lane, D.S.42
Langer, R.D.43
Lasser, N.L.44
Lewis, C.E.45
Limacher, M.C.46
Manson, J.E.47
more..
-
25
-
-
77955953084
-
Minimizing bias due to confounding by indication in comparative effectiveness research: The importance of restriction
-
Psaty BM, Siscovick DS. Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction. JAMA 2010;304:897-8.
-
(2010)
JAMA
, vol.304
, pp. 897-898
-
-
Psaty, B.M.1
Siscovick, D.S.2
-
26
-
-
3242771333
-
Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation
-
DOI 10.1111/j.1464-4096.2004.04831.x
-
Coxon JP, Oades GM, Kirby RS, Colston KW. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation. BJU Int 2004;94:164-70. (Pubitemid 38980328)
-
(2004)
BJU International
, vol.94
, Issue.1
, pp. 164-170
-
-
Coxon, J.P.1
Oades, G.M.2
Kirby, R.S.3
Colston, K.W.4
-
27
-
-
44649147055
-
Antitumor effects of bisphosphonates: Promising preclinical evidence
-
Guise TA. Antitumor effects of bisphosphonates: promising preclinical evidence. Cancer Treat Rev 2008;34 (Suppl 1):S19-S24.
-
(2008)
Cancer Treat Rev
, vol.34
, Issue.SUPPL. 1
-
-
Guise, T.A.1
-
28
-
-
52049125559
-
Hip bone density predicts breast cancer risk independently of Gail score: Results from the women's health initiative
-
Chen Z, Arendell L, Aickin M, Cauley J, Lewis CE, Chlebowski R. Hip bone density predicts breast cancer risk independently of Gail score: results from the women's health initiative. Cancer 2008;113:907-15.
-
(2008)
Cancer
, vol.113
, pp. 907-915
-
-
Chen, Z.1
Arendell, L.2
Aickin, M.3
Cauley, J.4
Lewis, C.E.5
Chlebowski, R.6
-
29
-
-
0031049425
-
Bone mass and the risk of breast cancer among postmenopausal women
-
DOI 10.1056/NEJM199702273360903
-
Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, Schatzkin A, Levy D, Felson DT. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997;336:611-17. (Pubitemid 27093406)
-
(1997)
New England Journal of Medicine
, vol.336
, Issue.9
, pp. 611-617
-
-
Zhang, Y.1
Kiel, D.P.2
Kreger, B.E.3
Cupples, L.A.4
Ellison, R.C.5
Dorgan, J.F.6
Schatzkin, A.7
Levy, D.8
Felson, D.T.9
-
30
-
-
0035918842
-
Bone mass and breast cancer risk in older women: Differences by stage at diagnosis
-
Zmuda JM, Cauley JA, Ljung BM, Bauer DC, Cummings SR, Kuller LH. Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 2001; 93:930-6. (Pubitemid 32624650)
-
(2001)
Journal of the National Cancer Institute
, vol.93
, Issue.12
, pp. 930-936
-
-
Zmuda, J.M.1
Cauley, J.A.2
Ljung, B.-M.3
Bauer, D.C.4
Cummings, S.R.5
Kuller, L.H.6
-
31
-
-
78649900291
-
Sex hormones and colorectal cancer: What have we learned so far?
-
Lin JH, Giovannucci E. Sex hormones and colorectal cancer: what have we learned so far? J Natl Cancer Inst 2010;102:1746-7.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 1746-1747
-
-
Lin, J.H.1
Giovannucci, E.2
-
32
-
-
45849145754
-
Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women
-
Ganry O, Lapotre-Ledoux B, Fardellone P, Dubreuil A. Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women. Eur J Epidemiol 2008;23:467-73.
-
(2008)
Eur J Epidemiol
, vol.23
, pp. 467-473
-
-
Ganry, O.1
Lapotre-Ledoux, B.2
Fardellone, P.3
Dubreuil, A.4
-
33
-
-
0035156721
-
Bone mass and the risk of colon cancer among postmenopausal women: The Framingham Study
-
DOI 10.1093/aje/153.1.31
-
Zhang Y, Felson DT, Ellison RC, Kreger BE, Schatzkin A, Dorgan JF, Cupples LA, Levy D, Kiel DP. Bone mass and the risk of colon cancer among postmenopausal women: the Framingham study. Am J Epidemiol 2001;153:31-7. (Pubitemid 32041894)
-
(2001)
American Journal of Epidemiology
, vol.153
, Issue.1
, pp. 31-37
-
-
Zhang, Y.1
Felson, D.T.2
Ellison, R.C.3
Kreger, B.E.4
Schatzkin, A.5
Dorgan, J.F.6
Cupples, L.A.7
Levy, D.8
Kiel, D.P.9
-
34
-
-
0348104878
-
Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort
-
Nelson RL, Turyk M, Kim J, Persky V. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2002;2:22.
-
(2002)
BMC Cancer
, vol.2
, pp. 22
-
-
Nelson, R.L.1
Turyk, M.2
Kim, J.3
Persky, V.4
-
35
-
-
34347406006
-
A systematic review of persistence and compliance with bisphosphonates for osteoporosis
-
DOI 10.1007/s00198-006-0322-8
-
Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007;18:1023-31. (Pubitemid 47019996)
-
(2007)
Osteoporosis International
, vol.18
, Issue.8
, pp. 1023-1031
-
-
Cramer, J.A.1
Gold, D.T.2
Silverman, S.L.3
Lewiecki, E.M.4
|